A client presents to the healthcare setting with an episode of status epilepticus. Which of the following rescue medications would be utilized in this scenario to assist in stopping the client's seizures?
benztropine (Cogentin)
phenytoin (Dilantin)
diazepam (Valium)
ethosuximide (Zarontin)
The Correct Answer is C
A. Benztropine (Cogentin) is an anticholinergic used primarily for Parkinson's disease and does not have an effect on seizure activity.
B. Phenytoin (Dilantin) is an antiepileptic medication, but it is not typically used as a rescue medication for immediate cessation of seizures in status epilepticus; it is used for long-term management.
C. Diazepam (Valium) is a benzodiazepine that acts quickly to stop seizures and is commonly used in acute situations, including status epilepticus, due to its rapid onset of action.
D. Ethosuximide (Zarontin) is primarily used for absence seizures and is not indicated for status epilepticus.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is D
Explanation
A. Paroxetine is an SSRI antidepressant used for depression and anxiety disorders, not for Parkinson's Disease.
B. Lisinopril is an ACE inhibitor primarily used for hypertension and heart failure, and it does not address symptoms of Parkinson's Disease.
C. Risperidone is an atypical antipsychotic that may be used in some cases for behavioral symptoms but is not a primary treatment for Parkinson's Disease.
D. Levodopa (Inbrija) is a medication specifically indicated for the management of Parkinson's Disease, as it helps to replenish dopamine levels, alleviating motor symptoms associated with the disease.
Correct Answer is B
Explanation
A. There is no established link between ciprofloxacin and endometrial cancers; this warning does not apply.
B. Ciprofloxacin has a black box warning for the risk of tendon rupture and tendinopathy, particularly in older adults and those concurrently taking corticosteroids.
C. Thromboembolic events are not specifically associated with ciprofloxacin; thus, this warning is not applicable.
D. Thrombocytopenia is a potential side effect of various medications but is not the primary concern associated with ciprofloxacin use.